z-logo
open-access-imgOpen Access
Neuropathologic characterization of a canine model of mucopolysaccharidosis IIIB and additional studies in anti-inflammatory therapy and neuroinflammatory kinetics
Author(s) -
Tyler A. Harm
Publication year - 2021
Language(s) - English
Resource type - Dissertations/theses
DOI - 10.31274/etd-20210609-65
Subject(s) - mucopolysaccharidosis , enzyme replacement therapy , glycosaminoglycan , mucopolysaccharidosis type i , heparan sulfate , lysosomal storage disease , pathology , mucopolysaccharidosis i , medicine , gliosis , genetic enhancement , spinal cord , pathogenesis , substrate reduction therapy , immunology , chemistry , biochemistry , gene , disease , anatomy , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom